Literature DB >> 3406410

Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications.

S W Atlas1, A S Mark, R I Grossman, J M Gomori.   

Abstract

Fifty-seven patients with hemorrhagic intracranial lesions were examined with magnetic resonance (MR) imaging at 1.5 T with use of both spin-echo (SE) and gradient-echo-acquisition (GEA) techniques to assess the clinical applications and limitations of GEA in evaluation of intracranial hemorrhage at high field strength. All GEA images were obtained with a long echo time and short flip angle to emphasize T2*-based contrast. In 30 of 61 cases, GEA images demonstrated more hemorrhagic lesions than SE images. In 14 of 61 cases, GEA images failed to depict the lesion or obscured the specific diagnosis (as depicted by SE MR imaging). The authors believe that GEA imaging in its current form has a limited but definite adjunctive role in the evaluation of intracranial hemorrhage at high field strength.

Entities:  

Mesh:

Year:  1988        PMID: 3406410     DOI: 10.1148/radiology.168.3.3406410

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  51 in total

1.  Diffuse axonal injury associated with chronic traumatic brain injury: evidence from T2*-weighted gradient-echo imaging at 3 T.

Authors:  Rainer Scheid; Cristoph Preul; Oliver Gruber; Christopher Wiggins; D Yves von Cramon
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

2.  Fast imaging.

Authors:  J R Hesselink; J F Martin; R R Edelman
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

3.  Clinical utility of partial flip angle T2-weighted spin-echo imaging of the brain.

Authors:  K H Chang; J G Yi; M H Han; M H Cho; M C Han; Z H Cho; C W Kim
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

4.  The importance of preoperative magnetic resonance imaging in valve surgery for active infective endocarditis.

Authors:  Yasushi Takagi; Yoshiro Higuchi; Hiroshi Kondo; Kiyotoshi Akita; Michiko Ishida; Kan Kaneko; Ryo Hoshino; Masato Sato; Motomi Ando
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-07-14

Review 5.  Clinical applications of susceptibility weighted MR imaging of the brain - a pictorial review.

Authors:  Bejoy Thomas; Sivaraman Somasundaram; Krishnamoorthy Thamburaj; Chandrasekharan Kesavadas; Arun Kumar Gupta; Narendra K Bodhey; Tirur Raman Kapilamoorthy
Journal:  Neuroradiology       Date:  2007-10-11       Impact factor: 2.804

6.  Comparison of subgroups based on hemorrhagic lesions between SWI and FLAIR in pediatric traumatic brain injury.

Authors:  Jong-Il Choi; Bum-Joon Kim; Sung-Kon Ha; Se-Hoon Kim; Dong-Jun Lim; Sang-Dae Kim
Journal:  Childs Nerv Syst       Date:  2014-01-10       Impact factor: 1.475

Review 7.  Structural and connectomic neuroimaging for the personalized study of longitudinal alterations in cortical shape, thickness and connectivity after traumatic brain injury.

Authors:  A Irimia; S Y Goh; C M Torgerson; P Vespa; J D Van Horn
Journal:  J Neurosurg Sci       Date:  2014-05-20       Impact factor: 2.279

8.  Brain microhemorrhages detected on T2*-weighted gradient-echo MR images.

Authors:  Yoshito Tsushima; Jun Aoki; Keigo Endo
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

9.  Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study.

Authors:  Matthew Schrag; Grant McAuley; Justine Pomakian; Arshad Jiffry; Spencer Tung; Claudius Mueller; Harry V Vinters; E Mark Haacke; Barbara Holshouser; Daniel Kido; Wolff M Kirsch
Journal:  Acta Neuropathol       Date:  2010-03       Impact factor: 17.088

10.  Cerebral venous thrombus signal intensity and susceptibility effects on gradient recalled-echo MR imaging.

Authors:  J L Leach; W M Strub; M F Gaskill-Shipley
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.